NNDC Study Shows TMS Demonstrates Efficacy In Clinical Practice
Lindner Center of HOPE served as recruitment site, contributing to study The National Network of Depression Centers (NNDC) presented results of a multi-site, naturalistic study of rTMS (Transcranial Magnetic Stimulation) for major depressive disorder at the May meeting of the Society of Biological Psychiatry in San Francisco. Lindner Center of HOPE, University Cincinnati College of Medicine and Lindner Center of HOPE Chief of Psychiatry, John M. Hawkins, MD, were one of nine key contributors to the study. The conclusion of the study stated that rTMS demonstrates efficacy in clinical practice within the NNDC, although response rates were slightly lower in comparison to a recent community-based sample. The study, sponsored by NNDC, was an open-label ‘registry’ study for patients receiving rTMS treatment for Major Depressive Disorders at 9 participating specialized academic centers. Patients were assessed pre-treatment (baseline) and weekly, up to 4-6 weeks during treatment. Forty-three patients were enrolled. Beyond Lindner Center of HOPE, recruitment sites included Duke University, McLean Hospital, Johns Hopkins University, Medical University of South Carolina, University of Louisville, University of Michigan, University of Pennsylvania and Weill Cornell Medical College.